A Study to Assess Relative Bioavailability and Food Effect of ABBV-668 Extended-Release Formulations in Adult Participants

The requested reference [ef0165f3cd14410f4fdad4725a0288b0dedca043] no longer exists in our database. It has been replaced by the current reference: [dfb8eb82ce199bcabce072d4b8aeb57baf1dee64]

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The objectives of this study are to assess safety and tolerability of the new ABBV-668 ER tablets, to assess the oral bioavailability of the ABBV-668 ER tablets relative to the ABBV-668 IR capsules, and to assess the pharmacokinetics of the ER tablets under fasting and fed conditions in healthy adults.
Epistemonikos ID: 4dd5c6c58f514b69379d75254bffdd1339329e2d
First added on: Jul 01, 2024